,Date,Title,URL,Journal,Severe,Severe lower bound,Severe upper bound,Severe p-value,Severe Significant,Severe Adjusted,Severe Calculated,Fatality,Fatality lower bound,Fatality upper bound,Fatality p-value,Fatality Significant,Fatality Adjusted,Fatality Calculated,Multivariate adjustment,Design,Sample,Study population,Added on,Critical only,Discharged vs. death?,Sample Text,Matches,Entry
,2020-08-31,Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers,https://doi.org/10.1016/j.dsx.2020.03.016,Diabetes & Metabolic Syndrome: Clinical Research & Reviews,,,,,,,,,,,,,,,,Retrospective observational,187.0,"Methods We have systematically searched the medical database up to March 27, 2020 and retrieved all the published articles in English language related to our topic using MeSH key words.",,,,"In a study of 187 patients with COVID-19, Guo et al.","found hypertension to have an odds ratio (OR) of 3.05 (95% CI, 1.57 to 5.92; p < 0.006), diabetes with OR of 2.85 (95% CI, 1.35 to 6.05; p < 0.001), whereas presence of coronary artery disease had an OR of 21.40 (95% CI, 4.64 to 98.76; p < 0.0001) for in-hospital mortality, in an univariate analysis .

found hypertension to have a hazard ratio (HR) of 1.82 (95% CI, 1.13 to 2.95; p ¼ 0.01) for acute respiratory distress syndrome (ARDS) and 1.70 (95% CI, 0.92 to 3.14, p ¼ 0.09) for death.

found hypertension to have a hazard ratio (HR) of 1.82 (95% CI, 1.13 to 2.95; p = 0.01) for acute respiratory distress syndrome (ARDS) and 1.70 (95% CI, 0.92 to 3.14, p = 0.09) for death.",2020-04-17
,2020-08-31,"Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations",https://doi.org/10.1016/j.dsx.2020.04.004,Diabetes & Metabolic Syndrome: Clinical Research & Reviews,,,,,,,,,,,,,,,,Retrospective observational,161.0,"Methods PubMed database and Google Scholar were searched using the key terms ‘COVID-19’, ‘SARS-CoV-2’, ‘diabetes’, ‘antidiabetic therapy’ up to April 2, 2020.",,,,A study in 161 patients with COVID-19 in Wuhan found increased time for viral clearance in patients with diabetes .,"the odds ratio (OR) of severe COVID-19 was not significantly higher in patients with diabetes (OR, 2.07; 95% CI, 0.89 to 4.82), unlike hypertension (OR, 2.36; 95% CI, 1.46 to 3.83) and CVD (OR, 3.42; 95% CI, 1.88 to 6.22).",2020-05-12
,2020-07-15,Myocardial injury and COVID-19: Possible mechanisms,https://doi.org/10.1016/j.lfs.2020.117723,Life Sci,,,,,,,,,,,,,,,,Cross-sectional,419.0,"in a single center in Wuhan, China examined mortality associated with CVD comorbidity and troponin T (TnT) elevation on admission .",,,,"In another case-series of 419 cases with COVID-19 in Shenzhen, China, patients were divided into 36 ICU patients and 383 non-ICU patients.","Hypertension, arrhythmia, cardiomyopathy and coronary heart disease are amongst major cardiovascular disease comorbidities seen in severe cases of COVID-19.",2020-05-12
,2020-06-30,Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu,https://doi.org/10.1016/j.jcv.2020.104366,Journal of Clinical Virology,,,,,,,,,,,,,,,,Case series,99.0,"We collected data for a total of 99 COVID-19 cases from Chengdu Public Health Clinical Medical Center from January 16, 2020, to February 20, 2020.",,,,"Study design This study included a retrospective, single-center case series of 99 consecutively hospitalized patients with confirmed COVID-19 at Chengdu Public Health Clinical Medical Center in Chengdu, China, from January 16 to February 20, 2020.","Of the total, 41 (41 %) patients had underlying disease, of which heart disease (21 %), including hypertension or coronary heart disease, was the most common, followed by diabetes (6 %).

Of the total, 41 (41 %) patients had underlying disease, of which heart disease (21 %), including hypertension or coronary heart disease, was the most common, followed by diabetes (6 % patients developed acute respiratory distress syndrome; and, among these patients, 3 (3 %) patients worsened in a short period of time and died of multiple organ failure.",2020-04-17
,2020-06-30,"The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region",https://doi.org/10.1016/j.ejca.2020.04.017,European Journal of Cancer,,,,,,,,,,,,,,,,Other,909.0,We extracted the data of laboratory-diagnosed patients with COVID-19 who had been referred to our division from 1st February 2020 and retrospectively gathered clinicopathological data.,,,,"In Italy, we report the analysis of the Italian Medical Council on 909 patients who died from COVID-19; of whom, 16.5% were patients with cancer.","More than 50% (n = 470) presented three or more comorbid conditions, including ischaemic heart disease, atrial fibrillation, heart failure, stroke, hypertension, diabetes mellitus, dementia, chronic respiratory disease, cancer, kidney diseases or liver diseases.",2020-05-12
,2020-05-07,Bleeding in COVID-19 severe pneumonia: the other side of abnormal coagulation pattern?,https://doi.org/10.1016/j.ejim.2020.05.002,European Journal of Internal Medicine,,,,,,,,,,,,,,,,Other,2.0,"To the Editor A novel coronavirus (SARS CoV-2) spread in China in December 2019, becoming soon a relevant problem of international public health concern .",,,,The two patients were both treated with interventional radiology.,The comorbidity were arterial hypertension and chronic ischemic heart disease.,2020-05-12
,2020-05-05,Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection,https://doi.org/10.1016/j.autrev.2020.102563,Autoimmunity Reviews,,,,,,,,,,,,,,,,Other,,We read with interest the recent article by McGonagle et al.,,,,One study of patients with heart failure showed that an increased level of IL-6 correlated with reduced activity of NK cells .,Patients with heart disease and hypertension may also be at greater risk from severe COVID-19 infection.,2020-05-12
,2020-04-29,"Key predictors of attending hospital with COVID19: An association study from the COVID Symptom Tracker App in 2,618,948 individuals",https://doi.org/10.1101/2020.04.25.20079251,medrxiv,,,,,,,,,,,,,,,,Prospective observational,,Objectives: We aimed to identify key demographic risk factors for hospital attendance with COVID-19 infection.,,,,,"Lung disease, diabetes, heart disease, advanced age and increased BMI were associated with risk of hospitalisation with COVID.",2020-05-12
,2020-04-29,Epidemiological and clinical characteristics of the early phase of the COVID-19 epidemic in Brazil,https://doi.org/10.1101/2020.04.25.20077396,medrxiv,,,,,,,,,,,,,,,,Case series,10.0,"Methods: Individual-level and aggregated COVID-19 data were analysed to investigate demographic profiles, socioeconomic drivers and age-sex structure of COVID-19 tested cases.",,,,"Overall, only four newborns, three infants (6 to 8 month-old), ten children (1 to 12 years old), and twelve adolescents (12 to 17 years old) were diagnosed with COVID-19.","Most common comorbidities were heart disease, hypertension, diabetes, and chronic respiratory disease.",2020-05-12
,2020-04-28,Marked Up-Regulation of ACE2 in Hearts of Patients with Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19,https://doi.org/10.1016/j.mayocp.2020.04.028,Mayo Clinic Proceedings,,,,,,,,,,,,,,,,Other,106.0,"All patients undergoing therapeutic surgical septal myectomy for symptomatic relief of obstructive HCM between January 1, 1999 and December 31, 2010 were eligible for inclusion in this study.",,,,Patients and Methods RNA was extracted from cardiac tissue flash frozen at therapeutic surgical septal myectomy for 106 patients with HCM and from 39 healthy donor hearts.,"A large meta-analysis of over 46,000 patients in China showed the most common co-morbidities were HTN (17±7%, 95% CI 14 -22%), diabetes mellitus (8±6% 95% CI 6-11%), and cardiovascular disease (5±4%, 95% CI 4-7%) 31 .",2020-05-01
,2020-04-28,Health Insurance Status and Risk Factors for Poor Outcomes With COVID-19 Among U.S. Health Care Workers: A Cross-sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197038/,Ann Intern Med,,,,,,,,,,,,,,,,Cross-sectional,,Moderate/severe asthma = Had an asthma attack in past 12 mo or had an emergency department visit for asthma in past 12 mo or used more than 3 canisters or disks of inhalers in past 3 mo.,,,,Moderate/severe asthma = Had an asthma attack in past 12 mo or had an emergency department visit for asthma in past 12 mo or used more than 3 canisters or disks of inhalers in past 3 mo.,"Serious heart condition = Ever told you had angina pectoris or coronary heart disease or a heart condition/disease or a heart attack.

Of these highrisk persons, 275 000 (CI, 154 000 to 396 000), or 7.5% (CI, 4.2% to 10.8%), were uninsured, including 11.4% (CI, 4.6% to 18.2%) of those with diabetes and 20.8% (CI, 13.8% to 27.8%) of those with chronic lung disease other than asthma.",2020-05-12
,2020-04-27,Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196305/,Theranostics,,,,,,,,,,,,,,,,Retrospective observational,625.0,"Methods: This retrospective cohort study enrolled patients with laboratory-confirmed COVID-19 from 24 designated hospitals in Jiangsu province, China, between 10 January and 18 February 2020.",,,,"Results: In this study, 625 laboratory-confirmed COVID-19 patients were enrolled; among them, 179 patients without an initial CT at admission and 25 patients aged < 18 years old were excluded and 421 patients were included in analysis.","Patients with an endpoint had a higher comorbidity proportion, including hypertension (20/64 [31%] vs. 50/357 [14%]), coronary heart disease (4/64 [6%] vs. 3/357 [1%]), and coronary heart disease (4/64 [6%] vs. 3/357 [1%]).",2020-05-12
,2020-04-27,Coronavirus disease 2019 in pregnancy,https://doi.org/10.1016/j.ijid.2020.04.065,International Journal of Infectious Diseases,,,,,,,,,,,,,,,,Retrospective observational,82.0,"All patients consecutively admitted in The Central Hospital of Wuhan with the diagnosis of COVID-19 between 15 January to 15 March 2020 were selected from the electronic medical records, and males were excluded.",,,,"Results Eighty-two patients (28 pregnant women, 54 reproductive-aged non-pregnant women) with laboratory confirmed COVID-19 were enrolled in this study.","No cancer, chronic respiratory disease and heart disease were reported.",2020-05-01
,2020-04-25,COVID-19 Fatality and Comorbidity Risk Factors among Confirmed Patients in Mexico,https://doi.org/10.1101/2020.04.21.20074591,medrxiv,,,,,,,,,,,,,,,,Other,7497.0,"In this paper we estimate fatality risks based on survival analysis methods, calculated from individual-level data on symptomatic patients confirmed with COVID-19 recently released by the Mexican Ministry of Health.",,,,"Our analysis is based on 7,497 patients who tested positive for COVID-19 in Mexico, a subset of a larger dataset of 49,167 patients with COVID-19 related symptoms who sought attention in medical units and were tested with positive, negative (29,301 cases) and pending (12,369 cases) results.","In contrast, high blood pressure increases the estimated hazard by 38% (HR=1.378, 95% CI: 1.086-1.749), immune suppression by 70% (HR=1.696, 95% CI: 1.148-2.505), diabetes by 73% (HR=1.730, 95% CI: 36.0-120.2), COPD by 77% (HR=1.770, 95% CI: 1.269-2.469), obesity by 78% (HR=1.776, 95% CI: 1.415-2.231), and chronic liver disease by 168% (HR=2.679, 95% CI: 1.789-4.014).",2020-05-01
,2020-04-22,Coronavirus Disease (COVID-19) Pandemic: An Overview of Systematic Reviews,https://doi.org/10.1101/2020.04.16.20068213,medrxiv,,,,,,,,,,,,,,,,Systematic review,1063.0,"Methods: Nine databases (Medline, EMBASE, Cochrane Library, CINAHL, Web of Sciences, PDQ-Evidence, WHO's Global Research, LILACS and Epistemonikos) were searched from December 1, 2019 to March 24, 2020.",,,,"Our search retrieved 1,063 publications, of which 175 were duplicates.","There was a higher likelihood that patients with severe disease had hypertension (OR 2.36, 95% CI: 1.46-3.83), respiratory disease (OR 2.46, 95% CI: 1.76-3.44), or cardiovascular disease (OR 3.42, 95% CI: 1.88-6.22), compared with patients with non-severe disease.

The most common comorbidities were hypertension (17±7, 95% CI 14-22%), diabetes (8±6, 95% CI 6-11%), cardiovascular diseases (5±4, 95% CI 4-7%) and respiratory system diseases (2±0, 95% CI 1-3%).",2020-05-01
,2020-04-21,Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure,https://doi.org/10.1016/j.chom.2020.04.009,Cell Host & Microbe,,,,,,,,,,,,,,,,Other,54.0,"We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF.",,,,"We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF.",Coronary heart disease 7 (14.6) 2 (7.7) 0.479 10 (17.9) 5 (17.9)* 1.0,2020-04-24
,2020-04-20,An Atypical Presentation of Novel Coronavirus Disease 2019 (COVID-19),https://doi.org/10.1016/j.amjmed.2020.03.026,The American Journal of Medicine,,,,,,,,,,,,,,,,Other,1.0,1 Some patients have experienced gastrointestinal symptoms such as diarrhea and nausea.,,,,1 Some patients have experienced gastrointestinal symptoms such as diarrhea and nausea.,"Hypertension, heart disease, and chronic lung disease are risk factors for severe disease.",2020-05-12
,2020-04-18,Social Isolation as a predictor for mortality: Implications for COVID-19 prognosis,https://doi.org/10.1101/2020.04.15.20066548,medrxiv,,,,,,,,,,,,,,,,Case series,994.0,"/2020 Willis, Haisten, and Vanessa Williams.",,,,"[Insert Table 1] Mortality Out of 994 participants (54% females vs. 46% males) with social isolation, 324 deaths were reported (including 71 CVD deaths) during an average of 10-year follow-up.","Presence of CVD was determined by identifying those individuals that had a self-reported diagnosis of coronary heart disease, angina, stroke, congestive heart failure (CHF), or heart attack.

For this study, cardiovascular mortality was defined as death due to diseases of the heart, essential hypertension and hypertensive kidney disease, cerebrovascular disease, atherosclerosis, and other diseases/disorders of the circulatory system (codes I00-I99).",2020-04-24
,2020-04-18,"Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China",https://doi.org/10.1016/j.eururo.2020.03.039,European Urology,,,,,,,,,,,,,,,,Case series,10.0,"Epidemiological, clinical, laboratory, and radiological characteristics, as well as treatment and outcome data, were obtained from electronic medical records.",,,,"Among the 10 transplant patients with COVID-19 pneumonia, eight were male and two were female.","Six patients had one or more of the following underlying diseases: hypertension, coronary heart disease, hypertensive heart disease, chronic obstructive pulmonary disease, atrial fibrillation, and chronic heart failure.",2020-04-24
,2020-04-17,Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184453/,Cardiovasc Res,,,,,,,,,,,,,,,,Other,187.0,"The emergence and consequent impact of COVID-19 has led to clinicians and academics looking for evidence, with clinical controversies to parallel socio-economical and political ones.",,,,"2 • Post-operative ACE2 levels following orthopaedic surgery in 187 patients were significantly greater in patients with a subsequent inhospital cardiac event (25.3 vs. 39.5 pmol/mL/min, P = 0.012), though this did not remain significant in multivariate analysis.","2  Hospitalization due to heart failure in the same cohort was associated with higher ACE2 with a HR of 1.0 (95% CI 1.4-11.5, P = 0.009).",2020-05-12
,2020-04-17,A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164701/,PMC,,,,,,,,,,,,,,,,Other,12.0,"In Hong Kong, Covid-19 testing was performed by Public Health Laboratory Services Branch for patients who fulfilled the enhanced surveillance criteria .",,,,A total of 12 patients with laboratory-confirmed Covid-19 infection in Hong Kong were included.,"Cardiovascular disease (CVD) is the group of disorders of heart and blood vessels and includes diseases such as atherosclerosis, myocardial infarction and coronary heart disease.",2020-04-24
,2020-04-16,"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia, Italy",https://doi.org/10.1101/2020.04.13.20063545,medrxiv,,,,,,,,,,,,,,,,Prospective observational,2653.0,"All 2653 symptomatic patients who tested positive for SARS-CoV-2 from February 27 to April 2, 2020 in the province of Reggio Emilia.",,,,"The cohort includes 2653 SARS-CoV-2 patients, representing all the resident symptomatic patients found positive at PCR from February 27 to April 2, 2020.","The highest risk of death was seen in patients with cardiovascular comorbidities (heart failure, arrhythmia, ischemic heart disease), followed by dementia and diabetes.

The strongest effects were for heart failure, arrhythmia, dementia, ischemic heart disease, diabetes, and hypertension, all with ≥ 50% excess hazard.

Risk of hospitalization and of death were higher in patients with heart failure (HR 1.6, 95% CI 1.2 to 2.1and HR 2.3, 95% CI 1.6 to 3.2, respectively), arrhythmia (HR 1.5, 95% CI 1.2 to 1.9 and HR 1.8, 95% CI 1.3 to 2.5, respectively), dementia (HR 1.2, 95% CI 0.9 to 1.8 and HR 1.8, 95% CI 1.1 to 2.8, respectively), ischemic heart disease (HR 1.3, 95% CI 1.0 to 1.7 and HR 1.7, 95% CI 1.2 to 2.5, respectively), diabetes (HR 1.5, 95% CI 1.3 to 1.9 and HR 1.6, 95% CI 1.1 to 2.2, respectively), and hypertensions(HR 1.4, 95% CI 1.2 to 2.6 and HR 1.6, 95% CI 1.2 to 2.1, respectively), while COPD increased the risk of hospitalization (HR 1.9, 95% CI 1.4 to 2.5) but not of death (HR 1.1, 95% CI 0.7 to 1.7).

However, this association disappeared when limiting the analysis to the subgroup of patients with ischemic heart disease, hypertension, or heart failure.",2020-04-24
,2020-04-15,"Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension COVID-19 Task Force Review of Evidence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184480/,Cardiovasc Res,,,,,,,,,,,,,,,,Other,104.0,"reports research grants from The French Ministry of Health, Quantum genomics, Idorsia, ReCor Medical, and the European H2020 program; grant support and non-financial support from ReCor Medical and Idorsia; and personal fees from CVRx outside the submitted work.",,,,104 COVID-19 patients with hypotension and particularly critically ill patients are highly susceptible to acute kidney injury (AKI).,"heart failure, chronic kidney diseases, and diabetes, when indicated.",2020-05-12
,2020-04-11,"Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City",https://doi.org/10.1101/2020.04.08.20057794,medrxiv,,,,,,,,,,,,,,,,Cross-sectional,4103.0,"Methods: We conducted a cross-sectional analysis of all patients with laboratory-confirmed Covid-19 treated at a single academic health system in New York City between March 1, 2020 and April 2, 2020, with follow up through April 7, 2020.",,,,"Results: Among 4,103 Covid-19 patients, 1,999 (48.7%) were hospitalized, of whom 981/1,999 (49.1%) have been discharged home, and 292/1,999 (14.6%) have died or were discharged to hospice.","Strongest hospitalization risks were age ≥75 years (OR 66.8, 95% CI, 44.7-102.6), age 65-74 (OR 10.9, 95% CI, 8.35-14.34), BMI>40 (OR 6.2, 95% CI, 4.2-9.3), and heart failure (OR 4.3 95% CI, 1.9-11.2).

In multivariable analysis, the factors most associated with hospitalization were age 75 years or older (OR 66.8, 95% CI, 44.7 to 102.6), age 65-74 (OR 10.9, 95% CI, 8.35 to 14.34), 1 1 BMI>40 (OR 6.2, 95% CI, 4.2-9.3), and history of heart failure (OR 4.3 95% CI, 1.9-11.2).",2020-04-17
,2020-04-11,Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust,https://doi.org/10.1101/2020.04.07.20056788,medrxiv,,,,,,,,,,,,,,,,Other,53.0,The study cohort was defined as all inpatients testing positive for SARS-Cov2 by RT-PCR at King's College Hospital and Princess Royal University Hospital from 1 March to 22nd March 2020.,,,,Findings:​ 53 patients out of 205 patients reached the primary endpoint.,"Baseline characteristics are 51·2% with hypertension, 30·2% with diabetes and 14·6% with ischaemic heart disease or heart failure.",2020-04-17
,2020-04-10,"COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies",https://doi.org/10.1016/j.jacbts.2020.04.002,JACC: Basic to Translational Science,,,,,,,,,,,,,,,,Other,3.0,"Following implementation of such measures in China, the R o steadily decreased from 2.38 prior to January 23 rd to 0.99 during the period of January 24-February 8, 2020 .",,,,Micro-and macro-thromboses were observed in autopsy evaluations of 3 patients who died from SARS-CoV1 (80) .,"Notably, patients with evidence of cardiac injury tend to be older with more comorbidities, including baseline hypertension, diabetes, coronary heart disease, and heart failure .",2020-04-17
,2020-04-09,COVID-19 and Diabetes: Knowledge in Progress,https://doi.org/10.1016/j.diabres.2020.108142,Diabetes Research and Clinical Practice,,,,,,,,,,,,,,,,Other,72314.0,"Methods We searched for articles in PubMed and Google Scholar databases till 02 April 2020, with the following keywords: “SARS-CoV-2”, “COVID-19”, “infection”, “pathogenesis”, “incubation period”, “transmission”, “clinical features”, “diagnosis”, “treatment”, “diabetes”, with interposition of the Boolean operator “AND”.",,,,"In a large Chinese report including 72,314 patients, only 2% of those infected were younger than 20 years old (20) .","One Chinese meta-analysis including 1527 patients showed that the most prevalent cardiovascular metabolic comorbidities with COVID-19 were hypertension (17.1%, 95% CI 9.9 -24.4%) and cardio-cerebrovascular disease (16.4%, 95% CI 6.6 -26.1%), followed by diabetes (9.7%, 95% CI 6.9 -12.5%).",2020-04-17
,2020-04-09,SARS-Cov-2 in Spanish Intensive Care: Early Experience with 15-day Survival In Vitoria,https://doi.org/10.1016/j.accpm.2020.04.001,Anaesthesia Critical Care & Pain Medicine,,,,,,,,,,,,,,,,Other,42.0,Methods: We identified patients from the two public hospitals in Vitoria who were admitted to ICU with confirmed infection by SARS-CoV-2.,,,,"Empirical antibiotic agents were administrated to 42 patients, whereas co-infection was identified in 6 patients.","Obesity Heart disease 23 (48%) 5 (10%) - - - - 10 (31%) -

Obesity Congestive heart failure 23 (48%) - - 9 (43%) - - 10 (31%) 1 (3%)",2020-04-17
,2020-04-08,The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184394/,Cardiovasc Res,,,,,,,,,,,,,,,,Other,99.0,"15, 22, 23 In 2019, a novel coronavirus (SARS-CoV-2) was identified in China and all over the world.",,,,"37 In another retrospective study of 99 patients with pneumonia, 40% had CV and cerebrovascular diseases.","In MERS-CoV patients, the prevalence of chronic heart disease and hypertension is 15% and 33%, respectively.",2020-05-12
,2020-04-08,A model to predict SARS-CoV-2 infection based on the first three-month surveillance data in Brazil.,https://doi.org/10.1101/2020.04.05.20047944,medrxiv,,,,,,,,,,,,,,,,Case series,1468.0,We included the patients reported between 11/01/2020 and 25/03/2020.,,,,Results: We described 1468 COVID-19 cases (confirmed by RT-PCR) and 4271 patients with other illnesses.,Variable Kidney disease OR (95% CI) 0.06 (0 - 1.06) p value 0.06,2020-04-17
,2020-04-03,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",https://doi.org/10.1016/s0140-6736(20)30566-3,The Lancet,,,,,,,,,,,,,,,,Retrospective observational,191.0,"Methods In this retrospective, multicentre cohort study, we included all adult inpatients (≥18 years old) with laboratory-confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020.",,,,"Findings 191 patients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) were included in this study, of whom 137 were discharged and 54 died in hospital.","In univariable analysis, odds of in-hospital death was higher in patients with diabetes or coronary heart disease (table 3) .",2020-04-10
,2020-04-02,Clinical features and outcomes of 2019 novel coronavirus-infected patients with high plasma BNP levels,https://doi.org/10.1101/2020.03.31.20047142,medrxiv,,,,,,,,,,,,,,,,Other,2019.0,"Aims To explore clinical features and outcome of 2019 novel coronavirus(2019-nCoV)-infected patients with high BNP levels Methods and results Data were collected from patients medical records, and we defined high BNP according to the plasma BNP was above > 100 pg/mL.",,,,"Aims To explore clinical features and outcome of 2019 novel coronavirus(2019-nCoV)-infected patients with high BNP levels Methods and results Data were collected from patients medical records, and we defined high BNP according to the plasma BNP was above > 100 pg/mL.","Underlying comorbidities in some patients were coronary heart disease (n=2, 20%) ;hypertesion(n=3;30%);, heart failure (n=1,10%)and diabetes (n=2, 20%).",2020-04-10
,2020-04-02,Population based estimates of comorbidities affecting risk for complications from COVID-19 in the US,https://doi.org/10.1101/2020.03.30.20043919,medrxiv,,,,,,,,,,,,,,,,Other,,"We used 2017 Behavioral Risk Factor Surveillance System (BRFSS) data (N=444,649) to estimate the proportion of US adults who report comorbidities that suggest heightened risk of complications from COVID-19.",,,,"Population Group Percent 18-29 95% CI 19.8 Sample Size 19.1-20.4 46,660","The copyright holder for this preprint (which was not peer-reviewed) is the The key variable was a composite measure including adults reporting they were ever told 67 they had cardiovascular disease (CVD: a heart attack, angina, coronary heart disease, or a 68 stroke), diabetes, current asthma (included as a chronic respiratory disease ), chronic 69 obstructive pulmonary disease (COPD), hypertension, and/ or cancer other than skin.",2020-04-10
,2020-03-31,Commentary: What is the relationship between Covid-19 and cardiovascular disease?,https://doi.org/10.1016/j.ijcard.2020.03.074,International Journal of Cardiology,,,,,,,,,,,,,,,,Other,136.0,26% of patients hospitalised at Zhongnan University Hospital of Wuhan required cardiovascular intensive care.,,,,A report on 136 Covid-19 patients shows that 26% of them required cardiovascular intensive care.,Hypertension or coronary heart disease is present in 38% and diabetes in 19% of COVID-19 patients .,2020-04-10
,2020-03-30,Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up,https://doi.org/10.1016/j.jinf.2020.03.019,Journal of Infection,,,,,,,,,,,,,,,,Retrospective observational,339.0,"Methods Consecutive cases over 60 years old with COVID-19 in Renmin Hospital of Wuhan University from Jan 1 to Feb 6, 2020 were included.",,,,"Results 339 patients with COVID-19 (aged 71±8 years,173 females (51%)) were enrolled, including 80 (23.6%) critical, 159 severe (46.9%) and 100 moderate (29.5%) cases.","Symptoms of dyspnea (HR 2.35, CI 1.43-3.87, P = 0.001) and comorbidities including cardiovascular disease (HR 2.87, CI 1.70-4.83, P < 0.001), cerebrovascular disease (HR 3.26, CI 1.66-6.40, P = 0.001) and COPD (HR 3.72, CI 1.94-7.13, P < 0.001) were all predictive of fatal outcomes.",2020-04-17
,2020-03-27,History of Coronary Heart Disease Increases the Mortality Rate of Coronavirus Disease 2019 (COVID-19) Patients: A Nested Case-Control Study Based on Publicly Reported Confirmed Cases in Mainland China,https://doi.org/10.1101/2020.03.23.20041848,medrxiv,,,,,,,,,,,,,,,,Case series,146.0,We routinely searched for daily news and public health reports on confirmed COVID-19 cases in all areas in mainland China outside of Hubei Province.,,,,"A total of 321 publicly reported confirmed cases (146 cases and 175 controls) with trackable time-to-death information and history of comorbidities were collected between December 18th, 2019 and March 8th, 2020.",Multivariate OR=odds ratio; CHD=coronary heart disease;,2020-04-10
,2020-03-26,"COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis",https://doi.org/10.1101/2020.03.24.20042903,medrxiv,,,,,,,,,,,,,,,,Systematic review,4789.0,"Methods: We reviewed the scientific literature published from January 1, 2019 to March 3, 2020.",,,,A total of 4789 patients with a mean age of 49 years were evaluated.,"The most common comorbidities were respectively hypertension (18.5 %, CI 12.7-24.4), 246 cardiovascular diseases (14.9 %, CI 6.0-23.8), diabetes (10.8 %, CI 8.3-13.3), chronic liver 247 disease (8.1, CI 4.6-11.6) and smoking (8.0%, CI 2.3-13.6) ( Table 3) .

The most prevalent comorbidities were hypertension (18.5 %, CI 12.7 to 24.4) and Cardiovascular disease (14.9 %, CI 6.0 to 23.8).

The most prevalent comorbidities in our study were hypertension (18.5 %, CI 12.7-24.4) followed 307 by cardiovascular diseases (14.9 %, CI 6.0-23.8) and diabetes (10.8 %, CI 8.3-13.3).",2020-04-03
,2020-03-26,Antihypertensive drugs and risk of COVID-19? – Authors' reply,https://doi.org/10.1016/s2213-2600(20)30159-4,The Lancet Respiratory Medicine,,,,,,,,,,,,,,,,Other,41.0,"As of March 22, 2020, 307 297 people have been infected by SARS-CoV-2, with 13 049 deaths and 92 382 people recovered.",,,,"3 In a second cohort of 41 patients hospitalised with COVID-19, 4 diabetes (20%), hypertension (15%), and cardiovascular disease (15%) were frequent comorbidities.","Of 1099 infected patients, 173 had severe disease, in whom the most common comorbidities were hypertension (24%), diabetes (16%), coronary heart disease (6%), and cerebrovascular disease (2%).",2020-05-12
,2020-03-26,Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184365/,J Crohns Colitis,,,,,,,,,,,,,,,,Other,13.0,"However, based on a PubMed search on March 17, 2020, we found no evidence to suggest that Covid-19 occurs more frequently in IBD patients than in the general population.",,,,"13 In vitro studies have shown that the latter form of ACE2 might act as a competitive interceptor of SARS-CoV-2 by preventing binding of the viral particle to the surface-bound, full-length ACE2.","with coronary heart disease, hypertension, diabetes mellitus, lung disease, cerebrovascular diseases], should stay at home and avoid public gatherings.",2020-05-12
,2020-03-23,Effectiveness and safety of antiviral or antibody treatments for coronavirus,https://doi.org/10.1101/2020.03.19.20039008,medrxiv,,,,,,,,,,,,,,,,Systematic review,3.0,"The database search returned a total of 4,491 citations, while the grey literature searches returned 305 citations, and 8 additional citations were identified from the articles provided by our knowledge users from the Public Health Agency of Canada for level 1 screening.",,,,"Three studies examining patients infected with COVID-19 were included in this review: one case report 35 and two case series 56,57 .","Common comorbidities included diabetes, heart disease, hypertension, and renal failure (Appendix 3).",2020-04-03
,2020-03-21,Building a COVID-19 Vulnerability Index,https://doi.org/10.1101/2020.03.16.20036723,medrxiv,,,,,,,,,,,,,,,,Other,,The data used was an anonymized 5% sample of the Medicare claims data from 2015 and 2016.,,,,"Cumulative Population Step 3,114,713 Building a COVID-19 Vulnerability Index • March, 2020 Selection Criteria  Total members in the dataset","is the (which was not peer-reviewed) The copyright holder for this preprint -0.020 CCSR:RSP016 age X Pneumonia 0.010 n/a age X Other and ill-defined heart disease 0.003 n/a age X Heart failure 0.009 n/a age X Acute rheumatic heart disease 0.003 n/a age X Coronary atherosclerosis and other heart disease 0.011 n/a age X Pulmonary heart disease -0.000 n/a age X Chronic rheumatic heart disease -0.001 n/a age X Diabetes mellitus with complication 0.007 n/a age X Diabetes mellitus without complication 0.009 n/a age X Chronic obstructive pulmonary disease and bronchiectasis 0.013 n/a age X Other specified and unspecified lower respiratory disease 0.006 n/a To turn this into a model, we extract ICD-10 diagnosis codes from the claims and aggregate them using the CCSR categories.",2020-04-03
,2020-03-20,"Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis",https://doi.org/10.1101/2020.03.17.20037572,medrxiv,,,,,,,,,,,,,,,,Systematic review,30.0,"Methods: The PubMed, Web of Science Core Collection, Embase, Cochrane and MedRxiv databases were searched through February 25, 2020.",,,,"Results: A total of 30 studies including 53000 patients with COVID-19 were included in this study, the mean age was 49.8 years (95% CI, 47.5-52.2 yrs) and 55.5% were male.","Comorbidities with pooled OR larger than 2 included CKD (6.02; 95% CI, 2.19-16.51; n = 4; I 2 = 0), COPD (5.32; 95% CI, ; n = 6; I 2 = 0%), cerebrovascular diseases (3.19 ; 95% CI, 1.51-6.77; n = 6; I 2 = 0%), tumor (3.21; 95% CI, ; n = 4; I 2 = 30%), diabetes (2.49; 95% CI, ; n = 10; I 2 = 44%) and hypertension (2.06; 95% CI, 1.61-2.62; n = 10; I 2 = 36%) ( Figure 4 , eFigure 5).

The predictor for disease severity included old age (≥ 50 yrs, odds ratio [OR] = 2.61; 95% CI, 2.29-2.98), male (OR =1.348, 95% CI, 1.195-1.521), smoking (OR =1.734, 95% CI, 1.146-2.626) and any comorbidity (OR = 2.635, 95% CI, 2.098-3.309), especially chronic kidney disease (CKD, OR = 6.017; 95% CI, 2.192-16.514), chronic obstructive pulmonary disease (COPD, OR = 5.323; 95% CI, 2.613-10.847) and cerebrovascular disease (OR = 3.219; 95% CI, 1.486-6.972).

The most common comorbidities were hypertension (19.0%, 95% CI, 13.2-24.9%), followed by diabetes (8.2%, 95% CI, 6.3-10.0%) and cardiovascular diseases (CVD, 2.7%, 95% CI, 1.4-4.1%).

Meanwhile, old age (≥ 60 yrs, RR = 9.45; 95% CI, 8.09-11.04), followed by cardiovascular disease (RR = 6.75; 95% CI, 5.40-8.43) hypertension (RR = 4.48; 95% CI, 3.69-5.45) and diabetes (RR = 4.43; 95% CI, 3.49-5.61) were found to be independent prognostic factors for the COVID-19 related death.

In support, COVID-19 related death was associated with old age ( ≥ 60 yrs, RR = 9.45; 95% CI, 8.09-11.04), male (RR = 1.67, 95% CI, 1.47-1.89) and any comorbidity (5.86; 95% CI, ), most notably CVD (6.75; 95% CI, 5.40-8.43) followed by hypertension (4.48; 95% CI, ) and diabetes (4.43; 95% CI, ).",2020-03-27
,2020-03-16,Building a COVID-19 Vulnerability Index,https://doi.org/,ArXiv,,,,,,,,,,,,,,,,Other,,The data used was an anonymized 5% sample of the Medicare claims data from 2015 and 2016.,,,,"Specifically, 4 categories of diagnoses were chosen from the Clinical Classifications Software Refined (CCSR) classification system:","In addition to the conditions -0.020 CCSR:RSP016 age X Pneumonia 0.010 n/a age X Other and ill-defined heart disease 0.003 n/a age X Heart failure 0.009 n/a age X Acute rheumatic heart disease 0.003 n/a age X Coronary atherosclerosis and other heart disease 0.011 n/a age X Pulmonary heart disease -0.000 n/a age X Chronic rheumatic heart disease -0.001 n/a age X Diabetes mellitus with complication 0.007 n/a age X Diabetes mellitus without complication 0.009 n/a age X Chronic obstructive pulmonary disease and bronchiectasis 0.013 n/a age X Other specified and unspecified lower respiratory disease 0.006 n/a coming from the recommendations of the CDC, we will look at features that our other modeling efforts surfaced as important and avail those features to the model as well.",2020-05-01
,2020-03-12,Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis,https://doi.org/10.1016/j.ijid.2020.03.017,Int J Infect Dis,,,,,,,,,,,,,,,,Systematic review,576.0,"A systematic search was conducted on studies published from January 1, 2019 to February 25, 2020 in PubMed, EMBASE, and Web of Science databases.",,,,"As of February 25, 2020, a total of 1 576 participants were included in our meta-analysis.","Higher risk of hypertension (OR 2.36, 95% CI: 1.46–3.83), respiratory system disease (OR 2.46, 95% CI: 1.76–3.44), and cardiovascular disease (OR 3.42, 95% CI: 1.88–6.22) were observed in the severe group.

Higher risk of hypertension (OR 2.36, 95% CI: 1.46-3.83), respiratory system disease (OR 2.46, 95% CI: 1.76-3.44), and cardiovascular disease (OR 3.42, 95% CI: 1.88-6.22) were observed in the severe group.

The most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0–27.2%) and diabetes (9.7%, 95% CI: 7.2–12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8–13.8%) and respiratory system disease (1.5%, 95% CI: 0.9–2.1%).

When compared between severe and non-severe patients, the pooled OR of hypertension, respiratory system disease, and cardiovascular disease were 2.36 (95% CI: 1.46–3.83), 2.46 (95% CI: 1.76–3.44) and 3.42 (95% CI: 1.88–6.22) respectively.

As shown in Figure 2 (inserts A, B, C, D), the most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0–27.2%) and diabetes (9.7%, 95% CI: 7.2–12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8–13.8%) and respiratory system disease (1.5%, 95% CI: 0.9–2.1%).

As shown in Figure 2 (inserts A, B, C, D), the most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0-27.2%) and diabetes (9.7%, 95% CI: 7.2-12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8-13.8%) and respiratory system disease (1.5%, 95% CI: 0.9-2.1%).",2020-05-12
,2020-03-06,How to differentiate COVID-19 pneumonia from heart failure with computed tomography at initial medical contact during epidemic period,https://doi.org/10.1101/2020.03.04.20031047,medrxiv,,,,,,,,,,,,,,,,Retrospective observational,12.0,"We included consecutive patients with diagnosis of COVID-19 pneumonia or heart failure who had CT imaging at the initial medical contact at the Second Xiangya Hospital of Central South University from Dec. 1 to Feb. 28, 2020.",,,,The study included 12 patients with heart failure and 12 patients with COVID-19 pneumonia.,"Heart failure COVID-19 P-value Values are n (%).

There were 6 patients with acute myocardial infarction, 4 patients with valve heart disease and 2 patients with cardiomyopathy in heart failure group.",2020-03-27
0,2020-04-29,"Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China",10.1101/2020.04.24.20078063,medrxiv,HR 1.6,0.64,4.01,0.32,Not Significant,Not Adjusted,Extracted,,,,,,,,,Prospective observational study,114,"Union Hospital from January 23, 2020 to February 22, 2020",5/6/2020,Y,N,,,
1,2020-04-28,Association of Cardiovascular Disease with Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis Association of Cardiovascular Disease with Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis,http://doi.org/10.1016/j.cpcardiol.2020.100617,Current Problems in Cardiology,OR 3.14,2.32,4.24,,Significant,Not Adjusted,Extracted,OR 11.08,2.59,47.32,,Significant,Not Adjusted,Extracted,,Systematic review and meta-analysis,18 studies enrolling 4858 patients,"Pubmed, Embase and Cochrane Central Register of Controlled Trials were searched from Nov 1 to April 20, 2020",5/6/2020,N,N,,,
2,2020-04-28,"Clinical determinants for fatality of 44,672 patients with COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187660/,Critical Care,,,,,,,,RR 6.75,5.4,8.43,<0.01,Significant,Not Adjusted,"Extracted RR, Calculated OR",,Case series,44672,"Chinese center for disease control and prevention (44,672 laboratory confirmed cases updated through February 11, 2020, [2])",5/6/2020,N,N,,,
3,2020-04-27,Estimating Survival of Hospitalized COVID-19 Patients from Admission Information,http://doi.org/10.1101/2020.04.22.20075416,medrxiv,,,,,,,,OR 2.57,2.11,3.14,<0.01,Significant,Not Adjusted,Calculated,,Retrospective observational study,5233,"Northwell Health acute care hospitals on or after March 1, 2020, and were discharged or died before April 12, 2020. Clinical outcomes (i.e., discharges, mortality, and length of stay) were monitored until April 12, 2020, the final date of follow-up",5/6/2020,N,Y,,,
4,2020-04-25,Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up,10.1101/2020.04.21.20074641,medrxiv,,,,,,,,OR 1.57,0.86,2.87,0.19,Not Significant,Adjusted,Extracted,"Age, ICU admission, PCR test results, admission week, number of comorbidities, gender, chronic lung disease, diabetes, chronic kidney disease, immunodeficiency, hypertension",Retrospective observational study,1197,"Qazvin province hospitals Feb 20-March 11, 2020",5/6/2020,N,N,,,
5,2020-04-23,Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis,https://doi.org/10.1016/j.jinf.2020.04.021,Journal of Infection,OR: 5.19,3.25,8.29,,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,3029 patients from 13 studies,China,5/6/2020,Y,N,,,
6,2020-04-23,Clinical Characteristics of Hospitalized Covid-19 Patients in New York City,https://doi.org/10.1101/2020.04.19.20062117,medrxiv,,,,,,,,OR 2.98,2.12,4.18,<0.01,Significant,Not Adjusted,Calculated,,Retrospective observational study,1078,"Mount Sinai Hospital located in East Harlem, Manhattan; Mount Sinai Morningside located in Morningside Heights, Manhattan; Mount Sinai West located in Midtown and the West Side, Manhattan; Mount Sinai Brooklyn located in Midwood, Brooklyn; and Mount Sinai Queens located in Astoria, Queens from Feb 25, 2020 to April 2, 2020",5/6/2020,N,Y,,,
7,2020-04-17,Clinical Characteristics of Covid-19 in New York City,10.1056/nejmc2010419,New England Journal of Medicine,OR 1.92,1.07,3.44,0.03,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,393,"2 hospitals in Manhattan from March 3 - March 27, 2020",5/6/2020,Y,N,,,
8,2020-04-17,Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui,http://doi.org/10.1016/j.jinf.2020.04.010,Journal of Infection,OR 2.15,0.8,5.76,0.13,Not Significant,Not Adjusted,Calculated,,,,,,,,,Observational study,167,"Anhui, China",5/6/2020,N,N,,,
9,2020-04-16,Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio,http://doi.org/10.1101/2020.04.13.20063545,,,,,,,,,HR 1.7,1.25,2.5,,Significant,Adjusted,Extracted,Age and gender,Retrospective observational study,2362,"All patients in Reggio Emilia, Italiy from Feb 27 to April 2, 2021",5/6/2020,N,N,,,
10,2020-04-16,Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio,https://doi.org/10.1101/2020.04.13.20063545,medRxiv,HR 1.3,1.0,1.7,,Not Significant,Not Adjusted,Extracted,HR 1.7,1.2,2.5,,Significant,Not Adjusted,Extracted,,Retrospective observational study,2653,"All symptomatic patients who tested positive in Reggio from February 27 to April 2, 2020.",5/6/2020,N,N,,,
11,2020-04-16,Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis [medrxiv],https://doi.org/10.1101/2020.04.12.20062869,medRxiv,4.19,1.27,13.8,,Significant,Not Adjusted,Extracted,OR 1.95,1.17,3.24,,Significant,Not Adjusted,Extracted,,Systematic review and meta-analysis,16 studies enrolling 3473 patients,"PubMed, Embase, Cochrane Library, Scopus, Web of Science as well as medRxiv pre-print database, Google Scholar and journal websites were searched",5/6/2020,Y,N,,,
12,2020-04-15,"Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection]",https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30217-2/pdf,Clinical Microbiology and Infection,OR 3.16,2.07,4.81,<0.01,Significant,Not Adjusted,Calculated,OR 5.89,2.55,13.59,0,Significant,Not Adjusted,Calculated,,Retrospective observational study,663,"Renmin Hospital of Wuhan University from January 11th to February 6th, 2020",5/6/2020,N,N,,,
13,2020-04-15,Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China Q28,http://doi.org/10.1016/j.chest.2020.04.010,,,,,,,,,HR 4.28,1.14,16.13,,Significant,Adjusted,Extracted,"Age, cerebrovascular disease, dyspnea, procalcitonin, AST",Retrospective observational study,1590,"575 hospitals in China through January 31, 2020",5/6/2020,N,N,,,
14,2020-04-12,Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severity and mortality in adult COVID-19 1 inpatients in Wuhan,http://doi.org/10.1016/j.jaci.2020.04.006,Journal of Allergy and Clinical Immunology,OR 5.29,2.15,12.98,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,548,"Sino-French New City Branch of Tongji Hospital, Huazhong University of Science and 161 Technology in Wuhan from January 26, 2020 to February 5, 2021",5/6/2020,N,N,,,
15,2020-04-11,"Factors associated with hospitalization and critical illness among 4,103 patients with",http://doi.org/10.1101/2020.04.08.20057794,medRxiv,OR 0.89,0.55,1.41,0.61,Not Significant,Not Adjusted,Extracted,,,,,,,,,Cross-sectional study,4103,"Single-center study in  New York City between March 1, 2020 and April 2, 2020, with follow up through April 7, 2024",4/21/2020,Y,N,,,
16,2020-04-03,History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study,https://doi.org/10.1101/2020.03.23.20041848,medRxiv,,,,,,,,AHR 3.0,1.8,5.0,<0.01,Significant,Adjusted,Extracted,"Age, gender, admitted before 1/11/2020, COPD, renal failure, cerebral infarction",Retrospective observational study,275,"mainland China outside of Hubei Province, from December 18th, 2019 to March 8, 2028",4/10/2020,N,N,,,
17,2020-04-03,History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study,https://doi.org/10.1101/2020.03.23.20041848,medRxiv,,,,,,,,HR 4.2,2.5,7.1,<0.01,Significant,Not Adjusted,Extracted,,Retrospective observational study,275,"mainland China outside of Hubei Province, from December 18th, 2019 to March 8, 2021",4/10/2020,N,N,,,
18,2020-04-02,"Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort",10.1016/j.jinf.2020.04.020,Journal of Infection,,,,,,,,OR 2.35,0.79,6.96,0.12,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,95,"North Bristol NHS Trust March 10 to March 30, 2020",5/6/2020,N,N,,,
19,2020-04-01,"Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis",https://doi.org/10.1101/2020.03.25.20043133,medRxiv,OR 2.85,1.68,4.84,<0.01,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,6 studies enrolling 1720 patients,"PubMed (1970-2020.03.06, English), Web of science (1950-2020.03.06, English), China National Knowledge Infrastructure Database (CNKI, 1979-2020.03.06, Chinese), WanFang Database (1970-2020.03.06, Chinese), and VIP Database (1970-2020.03.06, Chinese)",4/10/2020,N,N,,,
20,2020-03-27,"A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, China",http://doi.org/10.1101/2020.03.24.20042119,medRxiv,OR 3.13,1.33,7.35,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Prospective observational study,377,"Central Hospital of Wuhan from January 1 to February 28, 2020",4/10/2020,N,N,,,
21,2020-03-23,Prognostic value of C-reactive protein in patients with COVID-19,https://doi.org/10.1101/2020.03.21.20040360,medRxiv,,,,,,,,OR: 2.83,1.25,6.4,0.01,Significant,Not Adjusted,Calculated,,Retrospective observational study,298,"Eastern Campus of Renmin Hospital of Wuhan University from Jan 30 to Feb 20, 2020",4/10/2020,N,Y,,,
22,2020-03-23,"Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China",https://doi.org/10.1101/2020.03.19.20033175,medRxiv,,,,,,,,OR 2.70,1.34,5.43,<0.01,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,403,"Eastern Campus of Renmin Hospital, Wuhan University from Jan 30 to Feb 25, 2020",5/6/2020,N,Y,,,
23,2020-03-23,"Clinical Characteristics of Coronavirus Disease 2019 in Hainan, China",https://doi.org/10.1101/2020.03.19.20038539,medRxiv,OR 4.20,1.27,13.94,0.02,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,168,Hainan province from 22 January 2020 to 14 March 2020,5/6/2020,N,N,,,
24,2020-03-15,Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up,https://doi.org/10.1016/j.jinf.2020.03.021,Journal of Infection,,,,,,,,AHR 1.86,1.06,3.26,0.03,Significant,Adjusted,Extracted,"age, cerebrovascular disease, COPD",Prospective observational study,339,"age over 60 years old admitted to Renmin Hospital of Wuhan University from Jan 1 to Feb 6, 2020 (followed up until March 5)",4/10/2020,N,N,,,
25,2020-03-13,Epidemiological characteristics of confirmed COVID-19 cases in Tianjin,https://doi.org/10.3760/cma.j.cn112338-20200221-00146,Chinese Journal of Epidemiology,OR 1.05,1.06,1.08,,Significant,Not Adjusted,Extracted,,,,,,,,,Cross-sectional study,135,Tianjin from Jan 11-Feb 14,4/10/2020,N,N,,,
26,2020-03-10,Prognostic value of NT-proBNP in patients with severe COVID-19,https://doi.org/10.1101/2020.03.07.20031575,Respiratory Research,,,,,,,,HR 2.65,0.99,7.09,,Not Significant,Not Adjusted,Extracted,,Prospective observational study,54,Hubei General Hospital (followed for 15 days),4/10/2020,N,N,,,
27,2020-03-06,Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-22,https://www.ncbi.nlm.nih.gov/pubmed/32141280,Chinese Journal of Cardiovascular Diseases,OR 13.67,3.14,59.53,<0.01,Significant,Not Adjusted,Extracted,,,,,,,,,Cross-sectional study,150,"Tongji Hospital, excluding those with acute myocardial infarction",4/10/2020,N,N,,,
28,2020-03-06,Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-25,https://www.ncbi.nlm.nih.gov/pubmed/32141280,Chinese Journal of Cardiovascular Diseases,AOR 16.61,2.29,120.58,<0.01,Significant,Adjusted,Extracted,,,,,,,,"age, gender, hypertension, N-terminal pro-B-type natriuretic peptide, cardiac troponin I, hypersensitive C-reactive protein, blood creatinine",Cross-sectional study,150,"Tongji Hospital, excluding those with acute myocardial infarction",4/10/2020,N,N,,,
29,2020-03-05,Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pubmed/32173574,International Journal of Infectious Diseases,OR 3.42,1.88,6.22,,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,4 studies enrolling 1174 subjects,"PubMed, EMBASE, and Web of Science published between Jan 1 and Feb 25 2020",4/10/2020,N,N,,,
30,2020-03-04,"Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China",https://doi.org/10.1101/2020.03.04.20030395,medRxiv,OR 8.78,2.46,31.26,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Cross-sectional study,198,Shanghai Public Health Clinical Centre from January 20 up to February 15,4/10/2020,Y,N,,,
31,2020-03-02,"Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China",https://doi.org/10.1101/2020.03.02.20030452,medRxiv,OR 5.40,2.16,13.49,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,221,"Zhongnan Hospital of Wuhan University from January 2 to February 10, 2020 (followed-up through Feb 15)",4/10/2020,N,N,,,
32,2020-02-28,Clinical Characteristics of Coronavirus Disease 2019 in China,https://www.ncbi.nlm.nih.gov/pubmed/32109013/,New England Journal of Medicine,OR 4.74,1.84,12.16,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,1099,"552 hospitals in China between Dec 11, 2020 to Jan 29, 2020",4/10/2020,Y,N,,,
33,2020-02-28,Clinical Characteristics of Coronavirus Disease 2019 in China,https://www.ncbi.nlm.nih.gov/pubmed/32109013/,New England Journal of Medicine,OR 3.28,1.48,7.29,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,1099,"552 hospitals in China between Dec 11, 2020 to Jan 29, 2020",4/10/2020,N,N,,,
34,2020-02-09,Clinical characteristics of 2019 novel coronavirus infection in China,https://doi.org/10.1101/2020.02.06.20020974,New England Journal of Medicine,OR 3.28,1.48,7.29,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,1099,"552 hospitals in China between Dec 11, 2020 to Jan 29, 2020",5/6/2020,N,N,,,
35,2020-02-07,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",https://www.ncbi.nlm.nih.gov/pubmed/32031570,JAMA,OR 2.76,1.03,7.35,0.04,Significant,Not Adjusted,Calculated,,,,,,,,,Case series,138,"Zhongnan Hospital of Wuhan University from January 1 to January 28, 2020 (followed up through February 3)",4/10/2020,Y,N,,,
36,1905-07-12,Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV,https://doi.org/10.3760/cma.j.cn112148-20200220-00105,Chinese Journal of Cardiovascular Disease,,,,,,,,OR 7.66,1.66,35.35,0.01,Significant,Not Adjusted,Calculated,,Retrospective observational study,112,"West Hospital of Wuhan Union Hospital from January 20, 2020 to February 15, 2020",5/6/2020,N,Y,,,
